mobile screening
This follows the clearance for heart rate measurement on the FaceHeart mobile app in 2023.
PanopticAI also claims to be the first in the city to obtain US FDA clearance for software as a medical device.
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.